TP53 and colorectal cancer: Similarly, we suggest that it is of significance to explore whether the TSPYL5-driven mechanism works in other cancers with preponderant cytoplasm localization of p53 and abundant ectopic expression of TSPYL5, including part of breast, liver, and colorectal cancers [40].